Compass Therapeutics Inc (NASDAQ:CMPX) currently has a daily average trading volume of 1.04M but it saw 811970 shares traded in last market. With a market cap of 354.98M USD, the company’s current market price of $2.58 came falling about -1.15 while comparing to the previous closing price of $2.61. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.73 and as low as $0.76. In the recent trading on the day, stock has struck highest price mark of $2.57 while lowest mark touched by it was $2.68.
Taking a look at 20-day trading activity of Compass Therapeutics Inc (CMPX) gives us an average price of $1.83, while its current price level is -5.49% below from 52-week high level whereas it is 237.25% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.67 while that of 200 days or SMA-200 reads an average of $1.49. A closer look into the stock’s movement over the week reveals that its volatility is standing at 11.40% during that period while stretching the period over a month that increases to 13.78%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 75.49 which implies that the stock is in overbought territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the D. Boral Capital which initiated the stock as “Buy” in its note to investors issued on December 23, 2024, recommending a price target of $32 for it. Leerink Partners downgraded its recommendation for the stock as a “Market Perform” from “Outperform” on November 15, 2024 while assigning a price target range of $5-$4. Ladenburg Thalmann issued its recommendations for the stock as it upgraded the price target for the stock is $5.
Over the week, CMPX’s stock price is moving 29.00% up while it is 81.69% when we observe its performance for the past one month. Year-to-date it is 77.93% up and over the past year, the stock is showing an upside performance of 85.61%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of -0.09 while estimate for next year EPS is -0.33.
Currently, Compass Therapeutics Inc’s total number of outstanding shares is 137.59M with 12.51% of that held by the insiders while 73.51% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -33.00% and return on equity (ROE) at -32.01%. Stock’s beta reads 0.91. Stock has a price to book (P/B) ratio of 2.56 while price to sale or P/S ratio amounts to 417.62. Its return on asset (ROA) is -29.93% on average.
